Related Experiment Videos
Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host
F P Nestel1, K S Price, T A Seemayer
1Department of Physiology, McGill University, Montreal, Quebec, Canada.
Abstract:
In this report we have investigated macrophage (M phi) activity and tumor necrosis factor alpha (TNF-alpha) production during graft-vs.-host disease (GVHD). TNF-alpha production by M phi requires two signals: priming of M phi by interferon followed by triggering of TNF-alpha production and release by lipopolysaccharide (LPS). The state of M phi activation was examined in nonirradiated B6AF1 recipient mice injected with either 60 x 10(6) (acute GVHD) or 30 x 10(6) (nonlethal GVHD) parental B6 lymphoid cells. During the early phase of acute GVHD, administration of normally sublethal amounts of LPS-triggered release of significant amounts of TNF-alpha into the serum resulting in death of the animals within 36 h. Normal animals treated with the same dose of LPS neither died nor produced detectable amounts of serum TNF-alpha. In vitro studies demonstrated that M phi were primed during GVHD. The level of M phi priming was greater during acute GVHD than nonlethal GVHD since 100-fold less LPS was required to trigger killing of a TNF-alpha-sensitive cell line by M phi from acute GVHD animals. The amount of TNF-alpha released into the serum after LPS injection increased during the course of the GVHD and was significantly greater in acute GVH-reactive mice. Endogenous LPS was detected in the serum of acute GVH-reactive animals coincident with the onset of mortality. The data provide evidence that during GVHD M phi are primed as a result of the allogeneic reaction and that endogenous LPS therefore triggers M phi production of TNF-alpha resulting in the symptoms characteristic of acute GVHD.
Insights
Graft-versus-host disease (GVHD) primes macrophages, leading to lethal tumor necrosis factor alpha (TNF-alpha) release upon encountering lipopolysaccharide (LPS). This explains acute GVHD symptoms.
Area of Science:
- Immunology
- Transplantation Biology
Background:
- Macrophage (M phi) activation and tumor necrosis factor alpha (TNF-alpha) production are critical in graft-versus-host disease (GVHD).
- TNF-alpha release by M phi requires priming (e.g., by interferon) followed by triggering (e.g., by lipopolysaccharide - LPS).
Purpose of the Study:
- To investigate M phi activity and TNF-alpha production during GVHD.
- To determine the role of M phi priming and LPS in GVHD pathogenesis.
Main Methods:
- M phi activation state was examined in B6AF1 mice undergoing acute or nonlethal GVHD.
- In vitro studies assessed M phi priming using LPS and TNF-alpha-sensitive cell lines.
- Serum TNF-alpha and endogenous LPS levels were measured during GVHD.
Main Results:
- Acute GVHD induced M phi priming, making them hyperresponsive to LPS.
- LPS administration to GVHD mice caused lethal TNF-alpha release, unlike in normal mice.
- Endogenous LPS was detected in acute GVHD mice, correlating with mortality.
- M phi priming was more pronounced in acute GVHD than nonlethal GVHD.
Conclusions:
- GVHD primes M phi via the allogeneic reaction.
- Endogenous LPS then triggers primed M phi to produce TNF-alpha, causing acute GVHD symptoms.
- This mechanism highlights a key pathway in GVHD pathogenesis.